• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Interleukin-6 Receptor Inhibitor
    2 Drugs classified under this drug class


    All the Drug Class Drugs

    Actemra
    Roche
    RX
    partial basket chart
    Actemra

    Interleukin-6 Receptor Inhibitor. Tocilizumab 20 mg/ml.
    VIALS: 1, 4 x 80 mg/4 ml; 200mg/10 ml;
    400 mg/20 ml.
    RA : 8mg/kg bdy wt. I.V. 1 x every 4
    weeks.
    Pts. bdy wt. > 100 kg, dose exceed. 800
    mg/infus. not recommend. See lit. SJIA:
    <30 kg bdywt: 12 mg/kg bdywt, every
    2 wks; ≥30 kg bdywt: 8 mg/kg bdywt,
    every 2 wks.
    Reduce signs/sympts. in adult pts with
    mod-severe active rheum. arthrit. when
    inad. response to one/more DMARDS or
    TNF antags., or in pts unable to use
    DMARDs. Can be used alone/in comb. with
    methotrexate/other DMARDs. Reduce rate
    progress. joint damage as measured by
    X-ray, improve physic. funct. when in
    combinat. methotrexate. Tmt. active
    system. juv. idiopath. arthrit. in pts. > 2 yrs.
    C/I: Hypersens., active severe infects.

    Actemra 162 mg S.C.
    Roche
    RX
    partial basket chart
    Actemra 162 mg S.C.

    Interleukin-6 Receptor Inhibitor. Tocilizumab 162 mg / 0.9 ml.
    PRE- FILLED SYRINGE.: 4 x 162 mg/0.9 ml
    Inj. S.C. 162 mg once a week.
    In comb. with MTX, for the tmt. of moder.-
    severe active RA in adult pt. who have
    either responded inadequate. to, or who
    were intoler. to, prev. therapy with one or
    more DMARDs or TNF antagonists. In
    these pts., Tocilizumab can be given as
    monother. in case of intolerance to MTX or
    where continued tmt. with MTX is
    inappropriate.
    C/I: Hypersens., active severe infects.

    CLOSE